Monotherapy with a P2Y


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
09 05 2020
Historique:
received: 07 11 2019
revised: 31 01 2020
accepted: 04 02 2020
entrez: 11 5 2020
pubmed: 11 5 2020
medline: 28 5 2020
Statut: ppublish

Résumé

Antiplatelet therapy is recommended among patients with established atherosclerosis. We compared monotherapy with a P2Y In this systematic review and meta-analysis, all randomised trials comparing P2Y A total of nine randomised trials were identified and included in this study, and 42 108 patients randomly allocated to a P2Y Compared with aspirin monotherapy, P2Y Italian Ministry of Education.

Sections du résumé

BACKGROUND
Antiplatelet therapy is recommended among patients with established atherosclerosis. We compared monotherapy with a P2Y
METHODS
In this systematic review and meta-analysis, all randomised trials comparing P2Y
FINDINGS
A total of nine randomised trials were identified and included in this study, and 42 108 patients randomly allocated to a P2Y
INTERPRETATION
Compared with aspirin monotherapy, P2Y
FUNDING
Italian Ministry of Education.

Identifiants

pubmed: 32386592
pii: S0140-6736(20)30315-9
doi: 10.1016/S0140-6736(20)30315-9
pii:
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0
Purinergic P2Y Receptor Antagonists 0
Clopidogrel A74586SNO7
Ticagrelor GLH0314RVC
Ticlopidine OM90ZUW7M1
Aspirin R16CO5Y76E

Types de publication

Comparative Study Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1487-1495

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Mauro Chiarito (M)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.

Jorge Sanz-Sánchez (J)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Francesco Cannata (F)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.

Davide Cao (D)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.

Matteo Sturla (M)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Cristina Panico (C)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.

Cosmo Godino (C)

Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.

Damiano Regazzoli (D)

Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.

Bernhard Reimers (B)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.

Raffaele De Caterina (R)

University of Pisa, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Fondazione Villa Serena per la Ricerca, Città Sant'Angelo, Pescara, Italy.

Gianluigi Condorelli (G)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.

Giuseppe Ferrante (G)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.

Giulio G Stefanini (GG)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy. Electronic address: giulio.stefanini@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH